Dipentum
Product Images NDC 68151-0312

2 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dipentum (NDC 68151-0312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dipentum 01)

Structural Formula (Dipentum 01)
Chemical structure of Dipentum showing the molecular arrangement including two benzene rings connected by an azo (N=N) bond, each substituted with hydroxyl (OH), sodium carboxylate (COONa), and other groups.*
FDA Label Image

Label Image (Lbl681510312)

Label Image (Lbl681510312)
Dipentum 250 mg gelatin coated capsule label displaying active ingredient olsalazine sodium, lot number 270001, expiration date 12/17, Rx only designation, and NDC number 00037-6860-10. The labeler is Carilion Materials Management.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.